Cassava Sciences Inc. buy tbackenh
Start price
26.09.16
/
50%
€6.69
Target price
26.09.16
€17.43
Performance (%)
22.64%
End price
26.09.16
€8.21
Summary
This prediction ended on 26.09.16 with a price of €8.21. The prediction had a final performance of 22.64%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cassava Sciences Inc. | 3.021% | 3.021% | -22.215% | -92.927% |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% | 58.545% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% | 80.511% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% | 62.776% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% | 54.389% |
Comments by tbackenh for this prediction
In the thread Cassava Sciences Inc. diskutieren
Pain Therapeutics
Die Zulassung des Schmerzmittels wurde verweigert, 65% Kursverlust waren die Folge. Erscheint mir etwas übertrieben, setze auf Gegenreaktion.
(Vom Mitglied beendet)